SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (333)1/11/2002 8:18:25 PM
From: scaram(o)uche  Respond to of 337
 
Haven't followed it for ages. However, Mike King at Robbie Stephens used to cover it, and he rarely lets go of a stock.

I have very fond memories of VGIN.



To: keokalani'nui who wrote (333)1/31/2002 2:25:46 AM
From: Gulo  Read Replies (1) | Respond to of 337
 
A while back you mentioned VGNX v VGIN.
Their last Qreport stated "The Company ended the third quarter with $85.2 million in cash and marketable
securities." They were burning $6M/Q or so and had 23M shares outstanding.

Is the difference between the market cap and cash due to potential dilution, or is the company's prospects being discounted?
-g


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News